{"transactions":[{"id":737766,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:22:23.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":39567,"derivative":{"exercise_price":6.48,"expiration_date":"2036-06-11","underlying":"Series A Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001104659-26-074052","document":"tm2617570-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000110465926074052/tm2617570-5_4seq1.xml","form_type":"4"}},{"id":1116282,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-10T21:37:31.000Z","date":"2025-06-09","kind":"grant","planned":false,"acquired":true,"shares":32250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":32250,"derivative":{"exercise_price":5.33,"expiration_date":"2035-06-08","underlying":"Series A Common Stock","underlying_shares":32250},"source":{"system":"sec-edgar","filing":"0001104659-25-058221","document":"tm2517621-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000110465925058221/tm2517621-2_4seq1.xml","form_type":"4"}},{"id":1486715,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:05:44.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":9279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":9279,"derivative":{"exercise_price":4.64,"expiration_date":"2034-06-04","underlying":"Series A Common Stock","underlying_shares":9279},"source":{"system":"sec-edgar","filing":"0001104659-24-069632","document":"tm2416701-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000110465924069632/tm2416701-2_4seq1.xml","form_type":"4"}},{"id":1549529,"issuer":{"id":5273,"kind":"organization","name":"Sagimet Biosciences Inc."},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T00:17:03.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":73014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable over thirty-six (36) equal monthly installments following April 1, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":73014,"derivative":{"exercise_price":5.23,"expiration_date":"2034-03-31","underlying":"Series A Common Stock","underlying_shares":73014},"source":{"system":"sec-edgar","filing":"0001104659-24-043263","document":"tm2410971-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000110465924043263/tm2410971-3_4seq1.xml","form_type":"4"}},{"id":1862230,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T22:15:57.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":17500,"derivative":{"exercise_price":9.01,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-23-035564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919123035564/doc4.xml","form_type":"4"}},{"id":2244671,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T21:00:53.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":6376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest on the earlier of June 1, 2023 or the day prior to the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":6376,"derivative":{"exercise_price":2.09,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":6376},"source":{"system":"sec-edgar","filing":"0001209191-22-034178","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122034178/doc4.xml","form_type":"4"}},{"id":2291819,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-22T22:47:19.000Z","date":"2022-04-20","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":36424,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-025455","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122025455/doc4.xml","form_type":"4"}},{"id":2291818,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T22:47:19.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":21542,"price":115.17,"value":2480992.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.82 to $115.48 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-22-025455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122025455/doc4.xml","form_type":"4"}},{"id":2291817,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T22:47:19.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":28458,"price":114.36,"value":3254456.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.79 to $114.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22591,"source":{"system":"sec-edgar","filing":"0001209191-22-025455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122025455/doc4.xml","form_type":"4"}},{"id":2291816,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-22T22:47:19.000Z","date":"2022-04-20","kind":"exercise","acquired":true,"shares":50000,"price":22.14,"value":1107000.0,"ownership":{"direct":true},"balance_after":51049,"source":{"system":"sec-edgar","filing":"0001209191-22-025455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122025455/doc4.xml","form_type":"4"}},{"id":2300300,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"exercise","acquired":false,"shares":185060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":86424,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":185060},"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2300299,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"exercise","acquired":false,"shares":30275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.96,"expiration_date":"2024-06-26","underlying":"Ordinary Shares","underlying_shares":30275},"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2300298,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":91710,"price":110.0101,"value":10089026.271,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC."}],"balance_after":66673,"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2300297,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":215335,"price":110.009,"value":23688788.015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2300296,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"exercise","acquired":true,"shares":185060,"price":22.14,"value":4097228.4,"ownership":{"direct":true},"balance_after":216384,"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2300295,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-04-08T20:09:49.000Z","date":"2022-04-06","kind":"exercise","acquired":true,"shares":30275,"price":15.96,"value":483189.0,"ownership":{"direct":true},"balance_after":31324,"source":{"system":"sec-edgar","filing":"0001209191-22-023845","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122023845/doc4.xml","form_type":"4"}},{"id":2317681,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-23","kind":"exercise","acquired":false,"shares":26090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":30275,"derivative":{"exercise_price":15.96,"expiration_date":"2024-06-26","underlying":"Ordinary Shares","underlying_shares":26090},"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317680,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-25","kind":"sale","acquired":false,"shares":663,"price":110,"value":72930.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC."}],"balance_after":158383,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317679,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-24","kind":"sale","acquired":false,"shares":1481,"price":110,"value":162910.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC."}],"balance_after":159046,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317678,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":11699,"price":110.0109,"value":1287017.5191,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.115 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC."}],"balance_after":160527,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317677,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-23","kind":"sale","acquired":false,"shares":26090,"price":110.0039,"value":2870001.751,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.115 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317676,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-23","kind":"exercise","acquired":true,"shares":26090,"price":15.96,"value":416396.4,"ownership":{"direct":true},"balance_after":27139,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317675,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-07","kind":"gift","acquired":true,"shares":172226,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held of record by Riviera Equity LLC. The Reporting Person and his spouse share voting power over the securities held by Riviera Equity LLC."}],"balance_after":172226,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317674,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-07","kind":"gift","acquired":false,"shares":172226,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":72789,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317673,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-07","kind":"gift","acquired":true,"shares":66626,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":245015,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2317672,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-03-25T22:38:52.000Z","date":"2022-03-07","kind":"gift","acquired":false,"shares":66626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-22-021151","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122021151/doc4.xml","form_type":"4"}},{"id":2427788,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2022-01-24T22:06:27.000Z","date":"2022-01-21","kind":"exercise","acquired":false,"shares":5558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2022-01-21","expiration_date":"2022-01-21","underlying":"Ordinary Shares","underlying_shares":5558},"source":{"system":"sec-edgar","filing":"0001209191-22-004633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122004633/doc4.xml","form_type":"4"}},{"id":2427787,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-01-24T22:06:27.000Z","date":"2022-01-21","kind":"tax_withholding","acquired":false,"shares":2463,"price":86.42,"value":212852.46,"ownership":{"direct":true},"balance_after":67675,"source":{"system":"sec-edgar","filing":"0001209191-22-004633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122004633/doc4.xml","form_type":"4"}},{"id":2427786,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-01-24T22:06:27.000Z","date":"2022-01-21","kind":"exercise","acquired":true,"shares":5558,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70138,"source":{"system":"sec-edgar","filing":"0001209191-22-004633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122004633/doc4.xml","form_type":"4"}},{"id":2427785,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-24T21:58:12.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period."}],"balance_after":35000,"derivative":{"exercise_price":8.01,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-22-004627","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122004627/doc4.xml","form_type":"4"}},{"id":2441560,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2021."}],"balance_after":23286,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11642},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441559,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."}],"balance_after":5800,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11616},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441558,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":11067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023."}],"balance_after":11069,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11067},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441557,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":14514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":14514,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14514},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441556,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":17983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17983},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441555,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":9522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2022."}],"balance_after":9522,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9522},"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441554,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"tax_withholding","acquired":false,"shares":50666,"price":101.84,"value":5159825.44,"ownership":{"direct":true},"balance_after":64580,"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441553,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":47375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2022, the PSUs vested as to the number of shares reported above."}],"balance_after":115246,"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2441552,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2022-01-07T01:58:57.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":66822,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":67871,"source":{"system":"sec-edgar","filing":"0001209191-22-002291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919122002291/doc4.xml","form_type":"4"}},{"id":2456167,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-31T02:00:16.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":8575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":56365,"derivative":{"exercise_price":15.96,"expiration_date":"2024-06-26","underlying":"Ordinary Shares","underlying_shares":8575},"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2456166,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-12-31T02:00:16.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":8575,"price":110,"value":943250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021."}],"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2456165,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-12-31T02:00:16.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":8575,"price":15.96,"value":136857.0,"ownership":{"direct":true},"balance_after":9624,"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2456164,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-12-31T02:00:16.000Z","date":"2021-12-03","kind":"gift","acquired":false,"shares":1049,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2456163,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-12-31T02:00:16.000Z","date":"2021-08-25","kind":"gift","acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":178389,"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2456162,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-12-31T02:00:16.000Z","date":"2021-08-25","kind":"gift","acquired":false,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2098,"source":{"system":"sec-edgar","filing":"0001209191-21-071650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121071650/doc4.xml","form_type":"4"}},{"id":2621219,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-07-30T20:25:05.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":17418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":17418,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17418},"source":{"system":"sec-edgar","filing":"0001209191-21-048788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121048788/doc4.xml","form_type":"4"}},{"id":2621218,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-07-30T20:25:05.000Z","date":"2021-07-28","kind":"tax_withholding","acquired":false,"shares":3858,"price":102.5,"value":395445.0,"ownership":{"direct":true},"balance_after":8261,"source":{"system":"sec-edgar","filing":"0001209191-21-048788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121048788/doc4.xml","form_type":"4"}},{"id":2621217,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-07-30T20:25:05.000Z","date":"2021-07-28","kind":"grant","acquired":true,"shares":8708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On July 28, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2021 pursuant to an employee stock purchase program."}],"balance_after":12119,"source":{"system":"sec-edgar","filing":"0001209191-21-048788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121048788/doc4.xml","form_type":"4"}},{"id":2712291,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-05-14T22:12:02.000Z","date":"2021-05-14","kind":"sale","acquired":false,"shares":102925,"price":90.0058,"value":9263846.965,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":172226,"source":{"system":"sec-edgar","filing":"0001209191-21-032882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121032882/doc4.xml","form_type":"4"}},{"id":2846228,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":17416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."}],"balance_after":17416,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17416},"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2846227,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":4718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":4718,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4718},"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2846226,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":1045,"price":87.17,"value":91092.65,"ownership":{"direct":true},"balance_after":2362,"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2846225,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":2358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":3407,"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2846224,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-01","kind":"gift","acquired":true,"shares":3094,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":275151,"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2846223,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-02-19T22:00:24.000Z","date":"2021-02-01","kind":"gift","acquired":false,"shares":3094,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-21-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121012407/doc4.xml","form_type":"4"}},{"id":2899273,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-01-23T02:01:29.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":5556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":5558,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5556},"source":{"system":"sec-edgar","filing":"0001209191-21-004994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121004994/doc4.xml","form_type":"4"}},{"id":2899272,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-23T02:01:29.000Z","date":"2021-01-21","kind":"tax_withholding","acquired":false,"shares":2462,"price":77.43,"value":190632.66,"ownership":{"direct":true},"balance_after":4143,"source":{"system":"sec-edgar","filing":"0001209191-21-004994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121004994/doc4.xml","form_type":"4"}},{"id":2899271,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-23T02:01:29.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":5556,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6605,"source":{"system":"sec-edgar","filing":"0001209191-21-004994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121004994/doc4.xml","form_type":"4"}},{"id":2899270,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-23T02:01:29.000Z","date":"2021-01-19","kind":"gift","acquired":true,"shares":169132,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":272057,"source":{"system":"sec-edgar","filing":"0001209191-21-004994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121004994/doc4.xml","form_type":"4"}},{"id":2899269,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-23T02:01:29.000Z","date":"2021-01-19","kind":"gift","acquired":false,"shares":169132,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001209191-21-004994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121004994/doc4.xml","form_type":"4"}},{"id":2915714,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":14513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":29028,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14513},"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915713,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":65696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":65696},"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915712,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":17983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":17983,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17983},"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915711,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":34928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":34928,"derivative":{"underlying":"Ordinary Shares","underlying_shares":34928},"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915710,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"tax_withholding","acquired":false,"shares":134698,"price":73.28,"value":9870669.44,"ownership":{"direct":true},"balance_after":170181,"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915709,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":205638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above."}],"balance_after":304879,"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":2915708,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2021-01-07T02:05:07.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":98192,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":99241,"source":{"system":"sec-edgar","filing":"0001209191-21-002410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919121002410/doc4.xml","form_type":"4"}},{"id":3047663,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-08-25T21:16:03.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":1823,"price":76.23,"value":138967.29,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.18 to $76.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":102925,"source":{"system":"sec-edgar","filing":"0001209191-20-048263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120048263/doc4.xml","form_type":"4"}},{"id":3047662,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-08-25T21:16:03.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":27753,"price":75.73,"value":2101734.69,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.13 to $76.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104748,"source":{"system":"sec-edgar","filing":"0001209191-20-048263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120048263/doc4.xml","form_type":"4"}},{"id":3158072,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-05-07T20:27:56.000Z","date":"2020-05-05","kind":"sale","acquired":false,"shares":104994,"price":38,"value":3989772.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2020."}],"balance_after":132501,"source":{"system":"sec-edgar","filing":"0001209191-20-027690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120027690/doc4.xml","form_type":"4"}},{"id":3241255,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-28T22:00:12.000Z","date":"2020-02-26","kind":"gift","acquired":true,"shares":11452,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":237495,"source":{"system":"sec-edgar","filing":"0001209191-20-013971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120013971/doc4.xml","form_type":"4"}},{"id":3241254,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-28T22:00:12.000Z","date":"2020-02-26","kind":"gift","acquired":false,"shares":11452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total number of directly owned shares held by the Reporting Person has been adjusted to correct a typographical error made on his Form 4 filed on February 21, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total number of directly owned shares held by the Reporting Person has been adjusted to correct a typographical error made on his Form 4 filed on February 21, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-013971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120013971/doc4.xml","form_type":"4"}},{"id":3256525,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2020-02-22T01:08:03.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":30014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."}],"balance_after":30014,"derivative":{"underlying":"Ordinary Shares","underlying_shares":30014},"source":{"system":"sec-edgar","filing":"0001209191-20-011831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120011831/doc4.xml","form_type":"4"}},{"id":3256524,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-22T01:08:03.000Z","date":"2020-02-19","kind":"tax_withholding","acquired":false,"shares":6649,"price":36.06,"value":239762.94,"ownership":{"direct":true},"balance_after":11407,"source":{"system":"sec-edgar","filing":"0001209191-20-011831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120011831/doc4.xml","form_type":"4"}},{"id":3256523,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-22T01:08:03.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":15007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."}],"balance_after":18056,"source":{"system":"sec-edgar","filing":"0001209191-20-011831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120011831/doc4.xml","form_type":"4"}},{"id":3256522,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-22T01:08:03.000Z","date":"2020-02-14","kind":"gift","acquired":true,"shares":226043,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":226043,"source":{"system":"sec-edgar","filing":"0001209191-20-011831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120011831/doc4.xml","form_type":"4"}},{"id":3256521,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-02-22T01:08:03.000Z","date":"2020-02-14","kind":"gift","acquired":false,"shares":226043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3049,"source":{"system":"sec-edgar","filing":"0001209191-20-011831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120011831/doc4.xml","form_type":"4"}},{"id":3304210,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2020-01-23T21:17:16.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":11114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":11114,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11114},"source":{"system":"sec-edgar","filing":"0001209191-20-004651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120004651/doc4.xml","form_type":"4"}},{"id":3304209,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-01-23T21:17:16.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":2461,"price":38.25,"value":94133.25,"ownership":{"direct":true},"balance_after":229137,"source":{"system":"sec-edgar","filing":"0001209191-20-004651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120004651/doc4.xml","form_type":"4"}},{"id":3304208,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-01-23T21:17:16.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":231598,"source":{"system":"sec-edgar","filing":"0001209191-20-004651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120004651/doc4.xml","form_type":"4"}},{"id":3316411,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-05","kind":"exercise","acquired":false,"shares":65696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."}],"balance_after":65696,"derivative":{"underlying":"Ordinary Shares","underlying_shares":65696},"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3316410,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-05","kind":"exercise","acquired":false,"shares":17982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":35966,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17982},"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3316409,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":43541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":43541,"derivative":{"underlying":"Ordinary Shares","underlying_shares":43541},"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3316408,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-05","kind":"tax_withholding","acquired":false,"shares":69321,"price":36.1,"value":2502488.1,"ownership":{"direct":true},"balance_after":226043,"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3316407,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":72376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above."}],"balance_after":295364,"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3316406,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2020-01-07T23:19:52.000Z","date":"2020-01-05","kind":"exercise","acquired":true,"shares":83678,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":222988,"source":{"system":"sec-edgar","filing":"0001209191-20-002340","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919120002340/doc4.xml","form_type":"4"}},{"id":3391958,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-10-17T20:42:37.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":10000,"price":28,"value":280000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019."}],"balance_after":139310,"source":{"system":"sec-edgar","filing":"0001209191-19-053432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119053432/doc4.xml","form_type":"4"}},{"id":3391957,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-10-17T20:42:37.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":10000,"price":28.01,"value":280100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019."}],"balance_after":149310,"source":{"system":"sec-edgar","filing":"0001209191-19-053432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119053432/doc4.xml","form_type":"4"}},{"id":3423317,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-09-04T21:41:39.000Z","date":"2019-08-30","kind":"sale","acquired":false,"shares":1359,"price":28,"value":38052.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019."}],"balance_after":159310,"source":{"system":"sec-edgar","filing":"0001209191-19-048266","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119048266/doc4.xml","form_type":"4"}},{"id":3430185,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-22","kind":"exercise","acquired":false,"shares":4516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested and became exercisable on the first anniversary of March 23, 2015 (the date of grant), and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":271484,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-22","underlying":"Ordinary Shares","underlying_shares":4516},"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3430184,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-22","kind":"exercise","acquired":false,"shares":25060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested and became exercisable on the first anniversary of June 27, 2014 (the date of grant), and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":64940,"derivative":{"exercise_price":15.96,"expiration_date":"2024-06-26","underlying":"Ordinary Shares","underlying_shares":25060},"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3430183,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-22","kind":"exercise","acquired":true,"shares":4516,"price":22.14,"value":99984.24,"ownership":{"direct":true},"balance_after":160669,"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3430182,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-22","kind":"exercise","acquired":true,"shares":25060,"price":15.96,"value":399957.6,"ownership":{"direct":true},"balance_after":156153,"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3430181,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-21","kind":"sale","acquired":false,"shares":14201,"price":28.01,"value":397770.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019."}],"balance_after":131093,"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3430180,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-08-23T20:58:53.000Z","date":"2019-08-21","kind":"sale","acquired":false,"shares":56702,"price":28,"value":1587656.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,370 ordinary shares of the Issuer acquired by the reporting person on May 31, 2019 pursuant to an employee stock purchase program."}],"balance_after":145294,"source":{"system":"sec-edgar","filing":"0001209191-19-047330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119047330/doc4.xml","form_type":"4"}},{"id":3579788,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Restricted Stock Units","published_at":"2019-03-26T01:13:57.000Z","date":"2019-03-23","kind":"exercise","acquired":false,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 124,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 124,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-19-021269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119021269/doc4.xml","form_type":"4"}},{"id":3579787,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-26T01:13:57.000Z","date":"2019-03-23","kind":"tax_withholding","acquired":false,"shares":13733,"price":26.84,"value":368593.72,"ownership":{"direct":true},"balance_after":199626,"source":{"system":"sec-edgar","filing":"0001209191-19-021269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119021269/doc4.xml","form_type":"4"}},{"id":3579786,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-26T01:13:57.000Z","date":"2019-03-23","kind":"exercise","acquired":true,"shares":31000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":213359,"source":{"system":"sec-edgar","filing":"0001209191-19-021269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119021269/doc4.xml","form_type":"4"}},{"id":3638816,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-22T22:22:17.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":32064,"price":21.54,"value":690658.56,"ownership":{"direct":true},"balance_after":182359,"source":{"system":"sec-edgar","filing":"0001209191-19-012696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119012696/doc4.xml","form_type":"4"}},{"id":3638815,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":38167,"kind":"person","name":"Hoelscher Paul W.","position":1,"cik":"0001611468","reported_name":"Hoelscher Paul W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-22T22:22:17.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":72375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 20, 2019, the PSUs vested as to the number of shares reported above, upon the Issuer's determination that certain performance criteria had been met."},{"field":"shares","element":"transactionShares","label":"F1","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 20, 2019, the PSUs vested as to the number of shares reported above, upon the Issuer's determination that certain performance criteria had been met."}],"balance_after":214423,"source":{"system":"sec-edgar","filing":"0001209191-19-012696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1611468/000120919119012696/doc4.xml","form_type":"4"}}],"next_cursor":"2019-02-22T22:22:17.000000Z,3638815"}